SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose
M Di Filippo, D Ferraro, P Ragonese, L Prosperini… - Journal of …, 2024 - Springer
Background COVID-19 vaccines have been recommended to people with multiple sclerosis
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
(pwMS) and, to ensure durable immunity, a third booster dose has been administered in …
Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine
I Fyfe - Nature Reviews Neurology, 2021 - nature.com
An mRNA COVID-19 vaccine does not increase the short-term risk of relapses in people with
multiple sclerosis (MS), a new study indicates. Di Filippo et al. analysed data from 324 …
multiple sclerosis (MS), a new study indicates. Di Filippo et al. analysed data from 324 …
Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis
MI Stefanou, L Palaiodimou… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background Data are sparse regarding the safety of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccines in patients with multiple sclerosis (MS). Objective To …
coronavirus 2 (SARS-CoV-2) vaccines in patients with multiple sclerosis (MS). Objective To …
Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France: A Self-Controlled Case Series
Background and Objectives People with multiple sclerosis (MS) have an increased risk of
severe coronavirus infection due to their level of motor disability or exposure to certain …
severe coronavirus infection due to their level of motor disability or exposure to certain …
COVID-19 vaccination in patients with multiple sclerosis: what we have learnt by February 2021
A Achiron, M Dolev, S Menascu… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background: Since vaccination against coronavirus disease 2019 (COVID-19) became
available, risks related to vaccinating patients with multiple sclerosis (MS) need to be …
available, risks related to vaccinating patients with multiple sclerosis (MS) need to be …
Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review
F Nabizadeh, E Ramezannezhad… - Journal of Clinical …, 2022 - Elsevier
Background Concerns about vaccination increased among patients with multiple sclerosis
(MS) regarding side effects, efficacy, and disease exacerbation. Recently there were reports …
(MS) regarding side effects, efficacy, and disease exacerbation. Recently there were reports …
Acute attack in a patient with multiple sclerosis 2 days after COVID vaccination: a case report
M Seyed Ahadi, F Ghadiri, MA Ahraian… - Acta Neurologica …, 2023 - Springer
Discussion Sufficient data have been available to assure the safety of vaccination against
various diseases in MS patients [3, 4]. Now, facing an unexpected devastating pandemic …
various diseases in MS patients [3, 4]. Now, facing an unexpected devastating pandemic …
SARS-CoV-2 infection and vaccination outcomes in multiple sclerosis
JA Brunn, GL Dunietz, AR Romeo… - Neurology: Clinical …, 2022 - AAN Enterprises
Background and Objectives The effects of the SARS-CoV-2 vaccination and infection on
clinical outcomes, including relapse risk, have been insufficiently explored in people with …
clinical outcomes, including relapse risk, have been insufficiently explored in people with …
COVID-19 vaccination in patients with multiple sclerosis: safety and humoral efficacy of the third booster dose
S Dreyer-Alster, S Menascu, M Mandel… - Journal of the …, 2022 - Elsevier
Background As immunity against SARS-COV-2 wanes following first and second doses of
vaccination, a third dose is administered in several countries around the world. Similarly to …
vaccination, a third dose is administered in several countries around the world. Similarly to …
COVID‐19 vaccination and relapse activity: A nationwide cohort study of patients with multiple sclerosis in Denmark
D Stastna, F Elberling, L Pontieri… - European Journal of …, 2024 - Wiley Online Library
Background and purpose We evaluated whether there was a difference in the occurrence of
relapses pre‐and post‐COVID‐19 vaccination in a nationwide cohort of Danish patients with …
relapses pre‐and post‐COVID‐19 vaccination in a nationwide cohort of Danish patients with …